Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382931017> ?p ?o ?g. }
- W4382931017 abstract "Abstract The massive COVID-19 vaccine roll-out campaign illuminated a range of rare side effects, the most dangerous of which – vaccine-induced immune thrombotic thrombocytopenia (VITT) – is caused by adenoviral (Ad)-vectored vaccines. VITT occurrence had been linked to production of pathogenic antibodies that recognize an endogenous chemokine, platelet factor 4 (PF4). Mass spectrometry (MS)-based evaluation of the ensemble of anti-PF4 antibodies obtained from a VITT patient’s blood indicates that its major component is a monoclonal antibody. Structural characterization of this antibody reveals several unusual characteristics, such as the presence of an N -glycan in the Fab segment and high density of acidic amino acid residues in the CDR regions. A recombinant version of this antibody (RVT1) was generated by transient expression in mammalian cells based on the newly determined sequence. It captures the key properties of VITT antibodies, such as their ability to activate platelets in a PF4-dependent fashion. Homology modeling of the Fab segment reveals a well-defined polyanionic paratope, and the docking studies indicate that the polycationic segment of PF4 readily accommodates two Fab segments, cross-linking the antibodies to yield polymerized immune complexes. Their existence was verified with native MS by detecting assemblies as large as (RVT1) 3 (PF4) 2 , pointing out at FcγRIIa-mediated platelet activation as the molecular mechanism underlying VITT clinical manifestations. In addition to high PF4 affinity, RVT1 readily binds other polycationic targets, indicating a polyreactive nature of this antibody. This surprising polyspecificity not only sheds light on VITT etiology, but also opens up a range of opportunities to manage this pathology. Significance Statement Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a dangerous side effect of adenoviral-vectored vaccines that is linked to the emergence of autoantibodies recognizing platelet factor 4 (PF4). We have engineered a recombinant VITT antibody by sequencing a VITT patient-derived anti-PF4 monoclonal antibody that causes platelet activation and triggers thrombosis. This antibody was used to characterize architecture of the pathogenic immune complexes with a combination of biophysical and computational approaches, revealing the molecular mechanism of VITT. The results of this work demonstrate the critical role of electrostatics in PF4 recognition by the pathogenic antibody and the polyspecificity of the latter. Availability of the engineered VITT antibody will be invaluable for future studies aiming at understanding the general mechanistic features of autoimmune pathologies." @default.
- W4382931017 created "2023-07-04" @default.
- W4382931017 creator A5012698004 @default.
- W4382931017 creator A5025456372 @default.
- W4382931017 creator A5029878132 @default.
- W4382931017 creator A5031476297 @default.
- W4382931017 creator A5050273950 @default.
- W4382931017 creator A5070800706 @default.
- W4382931017 creator A5076373591 @default.
- W4382931017 creator A5084020372 @default.
- W4382931017 date "2023-07-01" @default.
- W4382931017 modified "2023-10-16" @default.
- W4382931017 title "Reverse engineering of a pathogenic antibody reveals the molecular mechanism of vaccine-induced immune thrombotic thrombocytopenia" @default.
- W4382931017 cites W108425301 @default.
- W4382931017 cites W1480646216 @default.
- W4382931017 cites W1987515292 @default.
- W4382931017 cites W2018569753 @default.
- W4382931017 cites W2055905702 @default.
- W4382931017 cites W2135792930 @default.
- W4382931017 cites W2149729927 @default.
- W4382931017 cites W2161607361 @default.
- W4382931017 cites W2262220648 @default.
- W4382931017 cites W2334348545 @default.
- W4382931017 cites W2338733954 @default.
- W4382931017 cites W2520557605 @default.
- W4382931017 cites W2749574427 @default.
- W4382931017 cites W2767056551 @default.
- W4382931017 cites W2768914400 @default.
- W4382931017 cites W2789361433 @default.
- W4382931017 cites W2885104246 @default.
- W4382931017 cites W2949131782 @default.
- W4382931017 cites W3008987650 @default.
- W4382931017 cites W3020669081 @default.
- W4382931017 cites W3033622602 @default.
- W4382931017 cites W3152102956 @default.
- W4382931017 cites W3154877986 @default.
- W4382931017 cites W3159201683 @default.
- W4382931017 cites W3160734451 @default.
- W4382931017 cites W3163296046 @default.
- W4382931017 cites W3180418018 @default.
- W4382931017 cites W3193614926 @default.
- W4382931017 cites W3201278446 @default.
- W4382931017 cites W3202237317 @default.
- W4382931017 cites W3203248391 @default.
- W4382931017 cites W3207724482 @default.
- W4382931017 cites W3208867896 @default.
- W4382931017 cites W3213016949 @default.
- W4382931017 cites W3215882035 @default.
- W4382931017 cites W3215988676 @default.
- W4382931017 cites W4200415303 @default.
- W4382931017 cites W4210712008 @default.
- W4382931017 cites W4210934681 @default.
- W4382931017 cites W4211055995 @default.
- W4382931017 cites W4220741413 @default.
- W4382931017 cites W4224839121 @default.
- W4382931017 cites W4225616587 @default.
- W4382931017 cites W4238285434 @default.
- W4382931017 cites W4280567542 @default.
- W4382931017 cites W4281296386 @default.
- W4382931017 cites W4281487984 @default.
- W4382931017 cites W4281703522 @default.
- W4382931017 cites W4288052700 @default.
- W4382931017 cites W4295788712 @default.
- W4382931017 cites W4307129586 @default.
- W4382931017 cites W4308146171 @default.
- W4382931017 cites W4308547876 @default.
- W4382931017 cites W4308733579 @default.
- W4382931017 cites W4310211620 @default.
- W4382931017 cites W4313555641 @default.
- W4382931017 cites W4319262320 @default.
- W4382931017 cites W4319879421 @default.
- W4382931017 cites W4320181390 @default.
- W4382931017 cites W4378676195 @default.
- W4382931017 cites W851112836 @default.
- W4382931017 doi "https://doi.org/10.1101/2023.06.30.547300" @default.
- W4382931017 hasPublicationYear "2023" @default.
- W4382931017 type Work @default.
- W4382931017 citedByCount "0" @default.
- W4382931017 crossrefType "posted-content" @default.
- W4382931017 hasAuthorship W4382931017A5012698004 @default.
- W4382931017 hasAuthorship W4382931017A5025456372 @default.
- W4382931017 hasAuthorship W4382931017A5029878132 @default.
- W4382931017 hasAuthorship W4382931017A5031476297 @default.
- W4382931017 hasAuthorship W4382931017A5050273950 @default.
- W4382931017 hasAuthorship W4382931017A5070800706 @default.
- W4382931017 hasAuthorship W4382931017A5076373591 @default.
- W4382931017 hasAuthorship W4382931017A5084020372 @default.
- W4382931017 hasBestOaLocation W43829310171 @default.
- W4382931017 hasConcept C104317684 @default.
- W4382931017 hasConcept C159047783 @default.
- W4382931017 hasConcept C159654299 @default.
- W4382931017 hasConcept C159973064 @default.
- W4382931017 hasConcept C185592680 @default.
- W4382931017 hasConcept C203014093 @default.
- W4382931017 hasConcept C40767141 @default.
- W4382931017 hasConcept C542903549 @default.
- W4382931017 hasConcept C55493867 @default.
- W4382931017 hasConcept C86803240 @default.
- W4382931017 hasConcept C8891405 @default.
- W4382931017 hasConcept C89560881 @default.